HBV News and Research

RSS
New machine learning framework predicts effects of genetic mutations in ‘dark matter’ regions

New machine learning framework predicts effects of genetic mutations in ‘dark matter’ regions

Researchers develop inexpensive blood test to diagnose hepatitis B patients

Researchers develop inexpensive blood test to diagnose hepatitis B patients

Mathematical model assesses efficacy, cost-effectiveness of screening strategies for HCV

Mathematical model assesses efficacy, cost-effectiveness of screening strategies for HCV

Scientists find how immune system helps to clear HBV infection after treatment interruption

Scientists find how immune system helps to clear HBV infection after treatment interruption

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

Many European countries lack comprehensive policy to eliminate viral hepatitis

Many European countries lack comprehensive policy to eliminate viral hepatitis

New, sensitive HBV assay may allow earlier detection of hepatocellular carcinoma

New, sensitive HBV assay may allow earlier detection of hepatocellular carcinoma

4 in 10 cancers preventable by adopting simple lifestyle changes

4 in 10 cancers preventable by adopting simple lifestyle changes

Texas Biomedical Research Institute tests promising new treatment for HBV infection

Texas Biomedical Research Institute tests promising new treatment for HBV infection

Daily aspirin therapy linked to reduced risk of HBV‐related liver cancer

Daily aspirin therapy linked to reduced risk of HBV‐related liver cancer

Report sheds light on global market for infectious disease immunoassays

Report sheds light on global market for infectious disease immunoassays

Shortage of Hepatitis B vaccine - prioritization of vaccinations announced in UK

Shortage of Hepatitis B vaccine - prioritization of vaccinations announced in UK

FDA approves new treatment for all HCV genotypes 1-6

FDA approves new treatment for all HCV genotypes 1-6

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

World Hepatitis Day – gearing towards eliminating viral hepatitis by 2030

World Hepatitis Day – gearing towards eliminating viral hepatitis by 2030

ECDC highlights need to scale-up efforts for eliminating viral hepatitis in Europe

ECDC highlights need to scale-up efforts for eliminating viral hepatitis in Europe

Princeton scientists test cell-culture system to aid study of HBV infections

Princeton scientists test cell-culture system to aid study of HBV infections

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

Study estimates number of cancer deaths in China attributable to potentially modifiable risk factors

Study estimates number of cancer deaths in China attributable to potentially modifiable risk factors

Survey finds wide variation in hepatitis B, C testing policy and practice across the EU/EEA

Survey finds wide variation in hepatitis B, C testing policy and practice across the EU/EEA